Specialty
Neurovascular devices
Last checked: Nov 19, 2026Source: openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
101
510(k), De Novo and PMA
Decisions, last 36 months
22
Recruiting device trials
73
Industry sponsored
Adverse event reports
4,770
Received Nov 1, 2025 to Nov 19, 2026
Part of
Latest FDA decisions
The 8 newest. A specialty is the FDA review panel, or a list of product codes for a narrower view.
K260600 · Decided Nov 4, 2026 · 253 days after receipt
Device type: Temporary Carotid Catheter For Embolic Capture (NTE) · Cardiology
- Neuroguard IEP® 3-in-1 Carotid Stent, Post-Dilation Balloon System with Integrated Embolic ProtectionPMA supplement
P240009-S006 · Decided Nov 4, 2026 · 401 days after receipt · Panel Track
Device type: Stent, carotid (NIM) · Cardiology
K262419 · Decided Aug 14, 2026 · 30 days after receipt
Device type: Device, Neurovascular Embolization (HCG) · Neurology & Neurosurgery
K261772 · Decided Jun 24, 2026 · 26 days after receipt
Device type: Device, Neurovascular Embolization (HCG) · Neurology & Neurosurgery
MicroPort NeuroTech (Shanghai) Co., Ltd.
K260351 · Decided May 20, 2026 · 106 days after receipt
Device type: Device, Neurovascular Embolization (HCG) · Neurology & Neurosurgery
P250009 · Decided Jan 30, 2026 · 315 days after receipt
Device type: Neurovascular Liquid Embolic Agent (SGU) · Neurology & Neurosurgery
K254221 · Decided Jan 27, 2026 · 29 days after receipt
Device type: Device, Neurovascular Embolization (HCG) · Neurology & Neurosurgery
- TRUFILL n-BCA Liquid Embolic System (LES), TRUFILL n-BCA Liquid Embolic System Procedural SetPMA supplement
P990040-S034 · Decided Dec 16, 2025 · 316 days after receipt · Panel Track
Device type: Neurovascular Liquid Embolic Agent (SGU) · Neurology & Neurosurgery
FDA decisions per month
Last 36 months, by decision date and pathway.
- 510(k)
- De Novo
- PMA
View as table
| Month | 510(k) | De Novo | PMA |
|---|---|---|---|
| Dec 23 | 0 | 0 | 0 |
| Jan 24 | 1 | 0 | 0 |
| Feb 24 | 0 | 0 | 1 |
| Mar 24 | 0 | 0 | 0 |
| Apr 24 | 0 | 0 | 0 |
| May 24 | 0 | 0 | 0 |
| Jun 24 | 0 | 0 | 0 |
| Jul 24 | 0 | 0 | 0 |
| Aug 24 | 1 | 0 | 0 |
| Sep 24 | 2 | 0 | 0 |
| Oct 24 | 0 | 0 | 1 |
| Nov 24 | 0 | 0 | 1 |
| Dec 24 | 0 | 0 | 0 |
| Jan 25 | 0 | 0 | 0 |
| Feb 25 | 1 | 0 | 0 |
| Mar 25 | 0 | 0 | 0 |
| Apr 25 | 0 | 0 | 1 |
| May 25 | 0 | 0 | 0 |
| Jun 25 | 0 | 0 | 1 |
| Jul 25 | 0 | 0 | 0 |
| Aug 25 | 0 | 0 | 0 |
| Sep 25 | 1 | 0 | 0 |
| Oct 25 | 1 | 0 | 0 |
| Nov 25 | 0 | 0 | 0 |
| Dec 25 | 1 | 0 | 2 |
| Jan 26 | 1 | 0 | 1 |
| Feb 26 | 0 | 0 | 0 |
| Mar 26 | 0 | 0 | 0 |
| Apr 26 | 0 | 0 | 0 |
| May 26 | 1 | 0 | 0 |
| Jun 26 | 1 | 0 | 0 |
| Jul 26 | 0 | 0 | 0 |
| Aug 26 | 1 | 0 | 0 |
| Sep 26 | 0 | 0 | 0 |
| Oct 26 | 0 | 0 | 0 |
| Nov 26 | 1 | 0 | 1 |
Recruiting device trials
Industry-sponsored device trials that are recruiting now, most recently updated first.
Recross Cardio, Inc.Not on our public-company list
NCT07172464 · 30 participants (planned) · Start Oct 9, 2025 · Primary completion Aug 2027
Device: Recross P3 Occluder (P3O) System · For: PFO; PFO - Patent Foramen Ovale; Cryptogenic Stroke and 2 more
Sites: Los Angeles, California; Gainsville, Florida; Boston, Massachusetts · 4 sites in all
Recross Cardio, Inc.Not on our public-company list
NCT07698951 · 15 participants (planned) · Start Jun 17, 2026 · Primary completion Aug 2027
Device: Recross P3 Occluder (P3O) System · For: PFO; PFO - Patent Foramen Ovale; Cryptogenic Stroke and 2 more
Sites: Belgrade, Serbia; Kamenitz, Serbia
- The Neuralert Stroke Monitor Pilot TrialRecruiting
Neuralert Technologies LLCNot on our public-company list
NCT06368193 · 50 participants (planned) · Start Dec 12, 2024 · Primary completion Nov 14, 2027
Device: Neuralert Monitor · For: Stroke; Surgery
Sites: Philadelphia, Pennsylvania
Imperative Care, Inc.Not on our public-company list
NCT07491952 · 750 participants (planned) · Start Mar 24, 2026 · Primary completion Mar 31, 2030
Device: Zoom System · For: Ischemic Stroke; Acute Stroke
Sites: Huntsville, Alabama; Walnut Creek, California; Tampa, Florida · 26 sites in all
Neuralink CorpNot on our public-company list
NCT07929792 · 10 participants (planned) · Start Nov 2026 · Primary completion Nov 2027
Device: N1 Implant; R1 Robot · For: Spinal Cord Injury; Amyotrophic Lateral Sclerosis; Chronic Ischemic Stroke and 1 more
Sites: Miami, Florida
Penumbra Inc.Public (PEN)
NCT07749170 · 250 participants (planned) · Start Jun 26, 2026 · Primary completion Sep 2028
Device: Endovascular Thrombectomy · For: Acute Ischemic Stroke; Acute Ischemic Stroke (AIS) Related to a Distal Occlusion
Sites: Englewood, Colorado; New Haven, Connecticut; Lexington, Kentucky · 10 sites in all
How new technology gets paid for
Recent Medicare coverage decisions that touch this specialty.
Reports received
4,770
Received Nov 1, 2025 to Nov 19, 2026. Includes 12 of another or unstated type.
Malfunction reports
3,678
77% of reports
Injury reports
994
21% of reports
Death reports
86
1.8% of reports
Adverse event reports received per month
By the date FDA received each report. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Nov 25 | 294 | 80 | 3 | 0 |
| Dec 25 | 349 | 79 | 3 | 0 |
| Jan 26 | 333 | 69 | 6 | 0 |
| Feb 26 | 218 | 87 | 5 | 0 |
| Mar 26 | 306 | 113 | 12 | 0 |
| Apr 26 | 296 | 78 | 4 | 0 |
| May 26 | 321 | 65 | 5 | 0 |
| Jun 26 | 314 | 90 | 9 | 0 |
| Jul 26 | 401 | 82 | 9 | 1 |
| Aug 26 | 290 | 91 | 15 | 0 |
| Sep 26 | 296 | 79 | 12 | 5 |
| Oct 26 | 260 | 81 | 3 | 6 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types with the most reports
Widely used device types get more reports. This is not a ranking of safety.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Boston Scientific ENROUTE Transcarotid Neuroprotection System, Material Number SR-200-NPS; Percutaneous catheterOpen, Classified
Z-2977-2026 · Started Jul 9, 2026 · Posted by FDA Aug 20, 2026
Reason given: Potential for arterial sheath tip separation or partial tip separation during use.
Cause as FDA categorized it: Under Investigation by firm · Device type: Temporary Carotid Catheter For Embolic Capture (NTE)
- Boston Scientific ENROUTE Transcarotid Neuroprotection System Plus, Material Number SR-250-NPS; Percutaneous catheterOpen, Classified
Z-2978-2026 · Started Jul 9, 2026 · Posted by FDA Aug 20, 2026
Reason given: Potential for arterial sheath tip separation or partial tip separation during use.
Cause as FDA categorized it: Under Investigation by firm · Device type: Temporary Carotid Catheter For Embolic Capture (NTE)
Z-2911-2026 · Started Jun 29, 2026 · Posted by FDA Aug 6, 2026
Reason given: Carotid stent and post-dilation balloon system with integrated embolic protection system has an integrated filter, that due to a wire-to-filter-bond issue, may fail to open following sheath retraction; and if this condition were to occur during a procedure, the result may be loss of intended integrated embolic...
Cause as FDA categorized it: Process control · Device type: Stent, Carotid (NIM)
Z-3326-2026 · Started Jun 25, 2026 · Posted by FDA Sep 28, 2026
Reason given: Due to incorrect label/product dimensions. Product is supposed to be 3.00 mm in diameter, but unit is packaging was a 2.50 mm in diameter.
Cause as FDA categorized it: Under Investigation by firm · Device type: Intracranial Aneurysm Flow Diverter (OUT)
- Pipeline Flex Embolization Device with Shield Technology, 3.00 mm x 12 mm 027 REF PED2-300-12. Intracranial aneurysm flow diverterOpen, Classified
Z-2773-2026 · Started Jun 8, 2026 · Posted by FDA Jul 22, 2026
Reason given: Incorrect labeling - embolization devices labeled as 3.0 mm x 20 mm implants contain 12 mm implants, and devices labeled as 3.0 mm x 12 mm implants contain 20 mm implants.
Cause as FDA categorized it: Labeling Change Control · Device type: Intracranial Aneurysm Flow Diverter (OUT)
- Pipeline Flex Embolization Device with Shield Technology, 3.00 mm x 20 mm 027 REF PED2-300-20. Intracranial aneurysm flow diverterOpen, Classified
Z-2774-2026 · Started Jun 8, 2026 · Posted by FDA Jul 22, 2026
Reason given: Incorrect labeling - embolization devices labeled as 3.0 mm x 20 mm implants contain 12 mm implants, and devices labeled as 3.0 mm x 12 mm implants contain 20 mm implants.
Cause as FDA categorized it: Labeling Change Control · Device type: Intracranial Aneurysm Flow Diverter (OUT)
- Brand Name: CGuard Prime Carotid Stent System, 135cm, 8mmx30mm Model/Catalog Number: CND0830Open, Classified
Z-2325-2026 · Started May 1, 2026 · Posted by FDA Jun 5, 2026
Reason given: Stent delivery system may encounter complications during deployment which may result in high resistance or inability to deploy the stent.
Cause as FDA categorized it: Component design/selection · Device type: Stent, Carotid (NIM)
- Brand Name: CGuard Prime Carotid Stent System, 135cm, 8mmx40mm Model/Catalog Number: CND0840Open, Classified
Z-2326-2026 · Started May 1, 2026 · Posted by FDA Jun 5, 2026
Reason given: Stent delivery system may encounter complications during deployment which may result in high resistance or inability to deploy the stent.
Cause as FDA categorized it: Component design/selection · Device type: Stent, Carotid (NIM)
Showing the 8 newest of 159 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.